{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:33:50Z","timestamp":1756996430286,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024018","name":"Programa de Desarrollo de las Ciencias B\u00e1sicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Advances in cancer treatments have determined an increase in survival rates. However, these lifesaving therapies may have a negative impact on reproductive health. To diminish the infertility risk; different fertility preservation strategies have been designed. Sperm freezing is the gold standard fertility preservation method in the case of post-pubertal men. The main objective of this study is to evaluate the fertility status of Uruguayan male cancer survivors who have gone through sperm freezing, as well as to assess oncofertility counseling received by these patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This is a descriptive, cross-sectional, observational, and transversal study. A survey was conducted on male cancer survivors who cryopreserved sperm between 1985 and 2021 in \u201cReprovita Lab and Biobank\u201d which is the only sperm bank in this country.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> One hundred thirty-five participants answered the survey. At the time of diagnosis, the mean age of patients was 28.8 \u00b1 6.4 years old. Testicular was the most frequent type of cancer (64%). Only, 12% (<jats:italic>n<\/jats:italic> = 15) already had children at the time of diagnosis. Among the interviewed survivors, 50% (<jats:italic>n<\/jats:italic> = 62) attempted to conceive after cancer treatment, and 68% (<jats:italic>n<\/jats:italic> = 42) achieved natural pregnancy. Patients who did not achieve spontaneous conception (<jats:italic>n<\/jats:italic> = 11), used their cryopreserved samples, and 45.4% achieved pregnancy. About 86% (<jats:italic>n<\/jats:italic> = 107) of survivors believed that the timing of oncofertility referrals was appropriate and 97% considered that having the possibility of protecting their fertility was very important. Eighty percent (<jats:italic>n<\/jats:italic> = 101), were advised by their attending physicians, 14% (<jats:italic>n<\/jats:italic> = 18) sought advice from family members or friends, and 4% (<jats:italic>n<\/jats:italic> = 5) from oncofertility specialists.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> To our knowledge, this is the first study evaluating the reproductive outcomes of male cancer survivors in our country and the region. Most of the interviewed survivors considered fertility preservation as a positive initiative, independent of their reproductive outcomes, reflecting the importance of fertility preservation counseling as one of the most important aspects for futurequality of life of young cancer patients.<\/jats:p>","DOI":"10.3389\/fcell.2023.1240152","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:33:44Z","timestamp":1692279224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Fertility preservation in male cancer patients. Counseling and reproductive outcomes"],"prefix":"10.3389","volume":"11","author":[{"given":"Dana","family":"Kimelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Sapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e12838","DOI":"10.1111\/and.12838","article-title":"Interpretation of semen analysis using WHO 1999 and WHO 2010 reference values: abnormal becoming normal","volume":"50","author":"Alsharhrani","year":"2017","journal-title":"First Int. J. Androl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/life11121368","article-title":"The sixth edition of the WHO manual for human semen analysis: a critical Review and swot analysis","volume":"11","author":"Boitrelle","year":"2021","journal-title":"Life (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/jnci\/dji339","article-title":"Paternity following treatment for testicular cancer","volume":"97","author":"Brydoy","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/andr.12562","article-title":"Radiation effects on male fertility","volume":"7","author":"De Felice","year":"2019","journal-title":"Andrology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.fertnstert.2016.09.001","article-title":"Effect of first line cancer treatment on the ovarian reserve and follicular density in girls under the age of 18 years","volume":"106","author":"El Issaoui","year":"2016","journal-title":"Fertil. Steril."},{"key":"B6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.eururo.2021.08.025","article-title":"Expedited radical orchidectomy for testicular cancer: compromising fertility outcomes without oncological benefit?","volume":"80","author":"Emmanuel","year":"2021","journal-title":"Eur. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"877537","DOI":"10.3389\/fendo.2022.877537","article-title":"Fertility preservation and restoration options for pre-pubertal male cancer patients: current approaches","volume":"13","author":"Eugeni","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JCO.2009.24.9037","article-title":"Fertility of male survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"28","author":"Green","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/j.seminoncol.2009.07.006","article-title":"Testicular cancer: a prototypic tumor of young adults","volume":"36","author":"Hayes-Lattin","year":"2009","journal-title":"Semin. Oncol."},{"volume-title":"Incidencia cancer 2015 - 2019 por edad","year":"2019","key":"B10"},{"key":"B11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10815-010-9504-6","article-title":"Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer","volume":"28","author":"Kohler","year":"2011","journal-title":"J. Assist. Reprod. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"772809","DOI":"10.3389\/fonc.2021.772809","article-title":"Survey of long-term experiences of sperm cryopreservation in oncological and non-oncological patients: usage and reproductive outcomes of a large monocentric cohort","volume":"11","author":"Lackamp","year":"2021","journal-title":"Front. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: esmo clinical practice guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bju.14455","article-title":"Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway","volume":"123","author":"Moody","year":"2019","journal-title":"BJU Int. Androl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.coc.0000135736.18493.dd","article-title":"Fertility in men after treatment for stage 1 and 2A seminoma","volume":"27","author":"Nalesnik","year":"2004","journal-title":"Am. J. Clin. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: asco clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10147-021-02082-9","article-title":"Indications for fertility preservation not included in the 2017 Japan society of clinical Oncology guideline for fertility preservation in pediatric, adolescent, and young adult patients treated with gonadal toxicity, including benign diseases","volume":"27","author":"Ono","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"Fertil. Steril."},{"key":"B20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.juro.2011.10.154","article-title":"Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program","volume":"187","author":"Sheth","year":"2012","journal-title":"J. Urol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnci\/djq550","article-title":"Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries","volume":"103","author":"Stahl","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.fertnstert.2007.10.055","article-title":"Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients","volume":"90","author":"van Casteren","year":"2008","journal-title":"Fertil. Steril."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1240152\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:33:47Z","timestamp":1692279227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1240152\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":22,"alternative-id":["10.3389\/fcell.2023.1240152"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1240152","relation":{},"ISSN":["2296-634X"],"issn-type":[{"type":"electronic","value":"2296-634X"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"article-number":"1240152"}}